Fact CheckerSign in

NCT05942040Completed

Translating Data Science to Palliative Care

Translating Data Science to Palliative Care Practice for Persons Living With Dementia

Source: ClinicalTrials.gov · Last updated 18 Nov 2025

Brief summary (registry, in English)

This research study is intended to 1) better understand seriously ill adults' and their family care partners' (FCP), particularly for persons living with dementia (PLwD), barriers to accepting community-based palliative care (CBPC); 2) develop an intervention to address barriers; and 3) pilot test whether the intervention has an impact on CBPC uptake. The intervention will consist of 1) a set of informational material describing the benefits of CBPC for the CBPC team to use when presenting CBPC to members of a Medicare Advantage plan and their FCP; and 2) processes for tailoring information delivery so that eligible members and their FCP receive information about CBPC that reflects their individualized risk as identified by the Medicare Advantage program's validated 12-month mortality risk algorithm. The clinical trial portion of the study refers to the pilot test (Aim 3 as described below).

Status (registry)
Completed
Study type
Interventional
Enrollment
301 (actual)
First submitted
22 Jun 2023
Start date
15 Feb 2024
Primary completion date
30 Sept 2024
Lead sponsor
Rutgers, The State University of New Jersey
NCT number
NCT05942040

What you commit to

  • Study type: Interventional
  • Participants enrolled: 301
  • From 15 Feb 2024 to the primary completion date, 30 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • VNS Health Total plan members not identified as eligible for community-based palliative care by the palliative care team during the study period (6-month period prior to introduction of the intervention and the 6-month period following the intervention)

Age

  • under 18 years of age

Other

  • non-VNS Health Total Medicare Advantage Plan member

Who the study is looking for

  • VNS Health Total Medicare Advantage Plan member
  • identified as eligible for community-based palliative care by the VNS Health Total palliative care team during the study period (6-month period prior to introduction of the intervention and the 6-month period following the intervention)
  • 18 years of age or older

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
VNS Health
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.